Journal
JOURNAL OF BACTERIOLOGY
Volume 195, Issue 18, Pages 4129-4137Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/JB.00665-13
Keywords
-
Categories
Funding
- Russian Academy of Sciences Presidium
- Russian Government
- Russian Foundation for Basic Research [13-04-01631-a, 11-04-01846-a]
- FASIE
- Dmitry Zimin Dynasty Foundation
Ask authors/readers for more resources
Escherichia coli microcin B (Ec-McB) is a posttranslationally modified antibacterial peptide containing multiple oxazole and thiazole heterocycles and targeting the DNA gyrase. We have found operons homologous to the Ec-McB biosynthesis-immunity operon mcb in recently sequenced genomes of several pathovars of the plant pathogen Pseudomonas syringae, and we produced two variants of P. syringae microcin B (Ps-McB) in E. coli by heterologous expression. Like Ec-McB, both versions of Ps-McB target the DNA gyrase, but unlike Ec-McB, they are active against various species of the Pseudomonas genus, including human pathogen P. aeruginosa. Through analysis of Ec-McB/Ps-McB chimeras, we demonstrate that three centrally located unmodified amino acids of Ps-McB are sufficient to determine activity against Pseudomonas, likely by allowing specific recognition by a transport system that remains to be identified. The results open the way for construction of McB-based antibacterial molecules with extended spectra of biological activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available